title: Acute liver injury associated with glucosamine dietary supplement.
abstract: A 55-year-old woman taking  over-the-counter (OTC) glucosamine developed symptomatic hepatotoxicity. Several of her liver enzymes were elevated to 10 times the upper limit of normal. One week after discontinuing glucosamine, serum transaminases fell dramatically, with some returning to normal limits.  Four weeks after glucosamine was discontinued, all her liver tests were normal. Rechallenge was not attempted. The potential causes of hepatocellular injury were evaluated. Glucosamine is a dietary supplement available in a wide variety of commercial preparations, primarily used for joint relief in osteoarthritis. Despite the extensive use of glucosamine supplements, significant elevations of transaminases are rare. The mechanism of hepatotoxicity in many OTC herbal preparations is unknown. It is vital for physicians to elicit a careful history of OTC medications and educate their patients on their potential adverse effects.
authors.affiliation: Cleveland Clinic, Cleveland, Ohio,  USA.
authors.forename: Vivian
authors.initials: V
authors.lastname: Ebrahim
authors.forename: Mazen
authors.initials: M
authors.lastname: Albeldawi
authors.forename: Dian Jung
authors.initials: DJ
authors.lastname: Chiang
mesh_terms: D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D019587:Dietary Supplements / Q000009:adverse effects*; D005260:Female; D005944:Glucosamine / Q000009:adverse effects*; D006801:Humans; D008875:Middle Aged
chemical_list: D005944:Glucosamine